Cargando…
Correlation between serology and nucleic acid amplification test in blood donors who are reactive for hepatitis B virus, hepatitis C and human immunodeficiency virus and evaluation of the epidemiological profile of infected people in blood centers in the State of Paraná
OBJECTIVES: To compare the results of conventional serological tests and molecular technology (NAT, Nucleic Acid Amplification Test), identify donors in the diagnostic window period, and determine the prevalence of hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (H...
Autores principales: | Madeira, Heloise Skiavine, da Silva, Claudinei Mesquita, Scapini, Neila Cristina, de Peder, Leyde Daiane, Teixeira, Jorge Juarez Vieira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233538/ https://www.ncbi.nlm.nih.gov/pubmed/34194265 http://dx.doi.org/10.1016/j.jsps.2021.04.019 |
Ejemplares similares
-
Seroprevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) among human immunodeficiency virus (HIV)-infected patients in an HBV endemic area in Brazil
por: da Silva, Claudinei Mesquita, et al.
Publicado: (2018) -
Factors in enhancing blood safety by nucleic acid technology testing for human immunodeficiency virus, hepatitis C virus and hepatitis B virus
por: Shyamala, Venkatakrishna
Publicado: (2014) -
Individual donor-nucleic acid testing for human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus and its role in blood safety
por: Kumar, Rajesh, et al.
Publicado: (2015) -
Prevalence and trends of markers of hepatitis B virus, hepatitis C virus and human Immunodeficiency virus in Argentine blood donors
por: Flichman, Diego M, et al.
Publicado: (2014) -
The impact of nucleic acid testing to detect human immunodeficiency virus, hepatitis C virus, and hepatitis B virus yields from a single blood center in China with 10-years review
por: Wu, Danxiao, et al.
Publicado: (2022)